Zero-margin device conversions weighed on margins this quarter, management says.
RenovoRx, Inc. Common Stock (RNXT) News
Latest headlines that mention RNXT, newest first · each headline opens the original publisher
- Last price
- $1.16
- Day change
- +2.21%
- Next earnings
- —
RNXT headlines
latest coverageRecord $909K revenue driven by cancer center expansion and Phase III trial completion.
Image source: The Motley Fool. Thursday, May 14, 2026, at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
RNXT news alerts
Get an alert by email or push when a new headline mentions RNXT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.